Available online on 25.10.2022 at http://jddtonline.info

Journal of Drug Delivery and Therapeutics

Open Access to Pharmaceutical and Medical Research

Copyright   © 2022 The  Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

Open Access  Full Text Article                                                                                                                                                 Research Article 

Anti-Inflammatory Potential of Brucea javanica Fruit

Ifora Ifora1*, Rahmad Abdillah2, Ridum Shyntia1

Departement of Pharmacology and Clinical Pharmacy, School of Pharmaceutical Science Padang (STIFARM Padang), West SumateraIndonesia, 25147

Departement Pharmacology Faculty of Pharmacy, University of Andalas, Padang, West Sumatera, Indonesia

Article Info:

_____________________________________________

Article History:

Received 21 August 2022      

Reviewed 22 Sep 2022

Accepted 30 Sep 2022  

Published 25 Oct 2022  

_____________________________________________

Cite this article as: 

Ifora I, Abdillah R, Shyntia R, Anti-Inflammatory Potential of Brucea javanica Fruit, Journal of Drug Delivery and Therapeutics. 2022; 12(5-S):163-167

DOI: http://dx.doi.org/10.22270/jddt.v12i5-s.5661                          _____________________________________________

*Address for Correspondence:  

Ifora IforaDepartement of Pharmacology and Clinical Pharmacy, School of Pharmaceutical Science Padang (STIFARM Padang), West SumateraIndonesia, 25147

Abstract

___________________________________________________________________________________________________________________

Objective: Inflammation plays a crucial role in the progression of many diseases, excessive inflammation increases immune cell activation, which can destroy tissues and body health. When inflammation occurs, multiple pro-inflammatory mediators are overproduced, leading to a variety of diseases such as rheumatism, diabetes, and cardiovascular problems. Brucea javanica has been used as traditional medicine as a therapy for anti-tumor, amebic dysentery, diarrhea, malaria, and intestinal inflammation. Therefore, in this study, we explored the effect of ethanol extract Brucea javanica Fruit on anti-inflammation activity in carrageenan-induced rat paw edema and the COX-2 inhibitory effect in vivo.

Methods: In vivo anti-inflammatory activity of the ethanolic extracts was evaluated using the carrageenan-induced rat paws edema method at doses of 50, 100, and 200mg/kg and further investigated the effect of Cyclooxygenase-2 inhibitory using ELISA readers.

Results: The ethanolic extract of Brucea javanica Fruit exhibited anti-inflammatory activity by oral intake of 50 mg/kg of the ethanolic extract and Brucea javanica inhibited rat paw edema by 50.91% significantly compared to Celecoxib by 58.52%. Moreover, Brucea javanica showed COX-2 inhibition by 16,40% compared to Celecoxib by 20,50%. 

Conclusions:  These findings indicate that Brucae javanica Fruit extracts have promising anti-inflammatory activity directed against COX-2 enzymatic activity.

Keywords: Anti-inflammatory, Brucea javanica, Malur, Buah Makasar, Cyclooxygenase.

 


 

INTRODUCTION

Inflammation plays a crucial role in the progression of many diseases, excessive inflammation augments the activation of immune cells, which can destroy the tissues and body health 1. Multiple pro-inflammatory mediators are over-produced when inflammation occurs and leads to a series of diseases, such as rheumatism, diabetes, and cardiovascular ailments2,3.

Anti-inflammatory drugs such as Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) are the most successful drugs used in the world by a large number of patients 4. However, NSAIDs can cause various side effects including gastrointestinal (GI), and cardiovascular (CV) disturbances, high blood pressure, kidney toxicity, worsening of congestive heart failure, and hepatotoxicity 5–7.

Plants have played an important role in maintaining human health and improving the quality of human life for hundreds of years and serve as highly valuable medicines 8–11. Natural medicines have been increasingly used in recent years as alternative treatments for inflammation due to their relatively mild side effects  12–16. Previous studies have found that various plants have different pharmacological activities, including anti-inflammatory activity 17–19. One of the plants known to have many benefits, including Malur (Brucea javanica).  

Brucea javanica has been shown to have activities such as antitumor 20, antidiabetic21,  antihyperlipidemic22, antioxidantand antibacterial 23.

Thus, In this study, we investigated the effect of ethanol extract Brucea javanica Fruit on anti-inflammation activity in carrageenan-induced rat paw edema and the COX-2 inhibitory effect in vivo.

MATERIALS AND METHOD

Materials 

Rat PTGS2/COX-2 (Prostaglandin G/H synthase 2) ELISA Kit was purchased from Fine Biotech Co., Ltd. (Wuhan, China). Celecoxib was purchased from Pfizer Inc. (New York, NY, US). Carrageenan was obtained from Sigma-Aldrich (St. Louis, MO, USA) and other reagents were purchased from Bratachem (Indonesia).

The Brucea javanica Fruit were collected from SurantihWest Sumatera, Indonesia. The Brucea javanica were identified by Dr. Nurainas, a botanist at Herbarium of Andalas University, West Sumatera, Indonesia.   

Preparation of The Ethanol Extract of Brucea javanica Fruit (EEBjF)

The Brucea javanica Fruit was sun-dried. The dried Brucea javanica was powdered using a conventional grinder. The powdered materials were then soaked in Ethanol (70%) for 24 hours by stirring at room temperature. The materials were filtered after 24 hours. The procedure was repeated three times. The filtrates were mixed and concentrated under vacuum using a rotary until a brownish semisolid extract was obtained, free of solvent. The extract was kept cold for further pharmacological testing.

Experimental Animal 

18 adult male Wistar rats with body weights of 200–250 g and aged 2-3 months were obtained from West Sumatera animal houses were used for this study. Animals were housed and cared for in standard conditions with 12 h light/dark circle and were fed with a standard pellet diet and water ad libitum. All the animals were acclimatized for a minimum period of 1 week prior to the experiment.  After 1 week, animals were randomly selected for different experimental groups (3 animal/ group) and used for the in vivo determination of anti-inflammatory activity. The rats were deprived of food, but not water, for 18–20 hours before an experiment. 

 

Phytochemical Screening

The qualitative phytochemical screening of the extracts was performed to identify the main groups of chemical constituents (alkaloids, saponins, steroid, terpenoids,  flavonoids, and phenols) present in the extracts using color reactions 24.

Evaluation of  Anti-Inflammatory activity

The anti-inflammatory activity was further examined by the carrageenan-induced rat paw edema method according to the method of Winter et al 25. The experimental groups consisted of 18 rats split into six groups, Group I: Negative control (Na.CMC 0,5% p.o only), Group II: positive control (Carrageenan 1% s.c ), Group III: Carrageenan 1% s.c + EEBjF (50 mg/kg BW p.o), Group IV: Carrageenan 1% s.c + EEBjF (100 mg/kg BW p.o), Group V: Carrageenan 1% s.c + EEBjF (200 mg/kg BW p.o), Group VI: comparative group (Carrageenan 1% s.c + Celecoxib 9 mg/kg p.o) were given 1 h before the injection of carrageenan.  

By injecting 0.1 ml of 1% carrageenan in 0.9% saline into the right hind paw of the rat, edema was caused. After 1 h, 0.1 ml 1% carrageenan was injected subcutaneously into the subplantar area of the right hind paw of each rat except those in Group I. Edema volume was determined every 1 hour for up to 6 hours after carrageenan administration. The paw volumes were measured by a plethysmometer. The volume difference between before and after the right paw injection was measured to obtain the results. The inflammation degree of the paw and the rate of edema inhibition were calculated as follows:  

% edema inhibition = (Vc −Vt) × 100/ Vc;  

Vc and Vt are the average edema volumes of the control and test groups, respectively. The animal blood was collected in a heparin-coated tube at the end of the third hour. Groups I–VI was used to determine the activities of COX-2. 

Evaluation of  COX – 2 Inhibitory Activity Rat serum was prepared at the 3rd hour after induction of Carrageenan 1%. EEBjF (50, 100, and 200 mg/kg BW)  was used for inhibition studies.The ability of the test compound to inhibit COX-2 was determined by using the Enzyme-Linked Immunosorbent Assay (ELISA) kit according to the manufacturer’s instructions. The product of this enzymatic reaction produced a distinct yellow color, determined by spectrophotometrically (Microplate reader) at 450 nm.

 

Statistical Analysis

The statistical software SPSS version 25 (SPSS Inc., Chicago, IL, USA) was used to analyze the data. Data were analyzed using one-way ANOVA followed by Duncan’s multiple range test. p <0.05 was considered significant.

RESULT AND DISCUSSION

Phytochemical Screening

The qualitative phytochemical screening of EEBjF revealed that alkaloids, terpenoids, steroids, flavonoids, saponins, and phenol were present in EEBjF,  as shown in table 1.

Table 1 Phytochemistry screening test result of Brucea javanica

 

Groups

Result

I

Alkaloid

+

II

Falvonoid

+

III

Phenolic

+

IV

Saponin

+

V

Steroid

+

VI

Terponoid

+

 

Anti-inflammatory Activity

In the present study, the edema was measured for 6h after carrageenan injection. EEBjF given at dose 50, 100, and 200 mg/kg BW were effective in inhibiting the induced paw edema (Table 2).

Tabel 2. Anti-inflammatory activity of Brucea javanica extract

 

Groups

Dose (mg/kg B.W)

Percentage (%) of paw edema inhibitiona

I

Negative control

(Na. CMC 0,5%)

-

 

II

Positive control

(0,1 mL Carrageenan 1%  )

-

-

III

EEBjF

5

50,91*

IV

EEBjF

100 

36,96*

V

EEBjF

200 

8,37

VI

Celecoxibb

9    

58,52*

aData are expressed as the mean  of Three observations (n = 3), bUsed as comparative group

* Significant difference compared to the positive control (P < 0.05)

 

Table 2 shows the effect of EEBjF and standard drug as compared to carrageenan control at different hours in the carrageenan-induced paw edema model. From Table 2, a significant anti-inflammatory activity of EEBjF could be confirmed through paw edema inhibition by 50,91%, 36,96% and 8,37% after 6 h, at 50100, and 200 mg/kg dosage, respectively, while celecoxib diminished paw edema by 58,52% at the same time. These results demonstrate that the EEBjF (50100, and 200 mg/kg) significantly   inhibited the inflammatory processes induced by the injection of carrageenan (p<0,005). These findings indicate that the EEBjF posses potent anti-inflammatory properties. 

COX-2 Inhibitory Effect 

The COX-2 Inhibitory effect of EEBjF could be confirmed through COX-2 inhibition by 16,40 %, 7,90 % and 3,80% after 3 h, at 50, 100, and 200 mg/kg dosage, respectively, while celecoxib diminished paw edema by 20,50 % at the same time. These findings show that the EEBjF (50, 100, and 200 mg/kg BW) significantly inhibited COX-2 (p<0,005). However, EEBjF (50 mg/kg BW) was the most potent COX 2 Inhibitory effect dose (Table 3).

Figure 1. clearly shows that a dose of 50mg/kg BW showed the most potency in inhibiting inflammation and inhibiting the enzyme cyclooxygenase-2. 

Table 3 Cyclooxigenase-2 inhibitor Activity of Brucea javanica extract

 

Groups

Dose (mg/kg B.W)

Percentage (%) of Cox-2 inhibitiona

I

Negative control  

(Na. CMC 0,5%)

-

-

II

Positive control 

(0,1 mL Carrageenan 1%  )

-

-

III

EEBjF

5

16,40

IV

EEBjF

100 

7,90

V

EEBjF

200 

3,80

VI

Celecoxibb

9    

20,50

aData are expressed as the mean  of Three observations (n = 3), bUsed as comparative group

* Significant difference compared to the positive control (P < 0.05)

 

image

Figure 1. Comparison of percent inhibition of inflammation and percent inhibition of cyclooxygenase-2 enzyme at 3 hours after carrageenan induction.

 

DISCUSSION

 Carrageenan-induced paw edema is a useful phlogistic tool for studying systemic anti-inflammatory drugs. This two-phase test is sensitive to the majority of clinically effective anti-inflammatory drugs. The first phase, which occurs within 1-2 hours of carrageenan injection, is caused by the release of serotonin as well as an increase in bradykinin, histamine, and prostaglandins in the inflammatory location. The second phase occurs 3-5 hours after carrageenan injection and is associated with kinin and prostaglandin production and release in the inflamed area 26,27. Throughout the second phase, The macrophages are known to produce more interleukin-1 (IL-1) which caused an increase in the accumulation of polymorphic nuclear cells (PMNs) in the inflammatory area. The lysosomal enzymes and active oxygen species released by activated PMNs cause connective tissue destruction and paw swelling 28

This study reported the anti-inflammatory activity of the ethanolic extract of Brucea javanica Fruit and the possible anti-inflammatory mechanism in the experimental model. In the present study, the EEBjF (50, 100, and 200 mg/kg) significantly  inhibited the inflammatory processes. This is indicated by the ability of EEBjF to significantly decrease rat paw swelling as shown in Tables 2. The study concluded that a dose of 50mg/kg EEBjF showed the highest percent inhibition of inflammation.

These results further corroborate previous studies that the Ethyl acetate fraction and Methanol extract of Brucea javanica seed at the dose of 50 mg/kg significantly reduced blood glucose levels 29,30. Other studies reported that Brucea javanica fruit seed extract exhibited the optimumanti-inflammatory activity at a concentration of 1%, with a 55.47%inhibition of protein denaturation31. Moreover, the leaves extract of Brucea javanica showed anti-inflammatory activity32

COX and 5-LOX are two key enzymes involved in the production of inflammatory mediators. Cox inhibitors are the main deviations from current pain, inflammation, and fever control therapy 33. Many COX-2 or 5-LOX inhibitors have been developed as anti-inflammatory drugs, but some have been withdrawn from the market, indicating the need for inhibitors with few side effects 34. Nonsteroidal anti-inflammatory drugs (NSAIDs) exert their analgesic effects by inhibiting cyclooxygenase activity, antipyretic, anti-inflammatory, and antithrombotic effects 35,36. The anti-inflammatory potential of Brucea javanica Fruit may be due to the presence of active phytoconstituents such as flavonoids 37. The previous report describes flavonoids can reduce the risk of atherosclerosis and atherothrombotic disease and several other inflammatory diseases 38–40. The flavanol quercetin was found to suppress the expression of COX 2 mRNA in rat paw pouch exudates cells, indicating that quercetin's anti-inflammatory action may be due in part to suppressing COX-2 up-regulation41. Because of their powerful antioxidant capacity, flavonoids can interfere with the oxidative synthesis of (Arachidonic Acid) AA from phospholipids and reduce the downstream production of inflammatory metabolites from AA metabolism, oxidative damage, and the initiation of inducible pathways of inflammation42. Other studies have demonstrated that flavonoids with antioxidant properties can reduce the cellular conversion of AA to MDA (Malondialdehyde) in patients with chronic inflammation43. Radical scavenging activities of phenolic and polyphenolic compounds have been shown in previous studies 44,45. There are also many studies on anti-inflammatory activities of plant extracts that contain flavonoids 46. Furthermore, Brucea javanica Fruit possessed enormous potential as a medicinal drug, particularly in cancer treatment and antioxidant 23. The significant antioxidant capacity and flavonoid content of the extract used may have contributed to the anti-inflammatory effect 47,48.

This is the first report on the potent COX-2 inhibitory properties of ethanol extract of Brucea javanica Fruit. The obtained results suggest that the biological effects of this natural compound may be due to inhibition of prostaglandin synthesis via the arachidonic acid pathway.

CONCLUSIONS

From the results of the present investigation, it can be concluded that the ethanol extract of Brucea javanica Fruit (EEBjF) possesses significant anti-inflammatory activity. The mechanism of anti-inflammatory action is thought to be mediated by COX-2 inhibition. The results presented also suggest the need for further research on the COX-1 inhibitory effect. 

CONFLICT OF INTEREST 

The authors declare that there are no conflicts of interest.

ACKNOWLEDGMENTS

The authors would like to thank all colleagues in the Department of Pharmacology and Clinical Pharmacy, School of Pharmaceutical Sciences Padang (STIFARM Padang) for the useful discussions.

REFERENCES

1. Medzhitov R. Overview Essay Inflammation 2010 : New Adventures of an Old Flame. 2010; 771-6. https://doi.org/10.1016/j.cell.2010.03.006

2. Rumzhum NN, Ammit AJ. Cyclooxygenase 2: Its regulation, role and impact in airway inflammation. Clin Exp Allergy. 2016; 46(3):397-410. https://doi.org/10.1111/cea.12697

3. Granger DN, Senchenkova E. Inflammation and the Microcirculation. Vol. 2, Colloquium Series on Integrated Systems Physiology: From Molecule to Function. 2010. 1-87 p. https://doi.org/10.4199/C00013ED1V01Y201006ISP008

4. Suthar SK, Lee HB, Sharma M. The synthesis of non-steroidal anti-inflammatory drug (NSAID)-lantadene prodrugs as novel lung adenocarcinoma inhibitors via the inhibition of cyclooxygenase-2 (COX-2), cyclin D1 and TNF-α-induced NF-κB activation. RSC Adv. 2014; 4(37):19283-93. https://doi.org/10.1039/c4ra00280f

5. Braun J, Baraliakos X, Westhoff T. Nonsteroidal anti-inflammatory drugs and cardiovascular risk - a matter of indication. Semin Arthritis Rheum. 2020; 50(2):285-8. https://doi.org/10.1016/j.semarthrit.2019.07.012

6. Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: An update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 2013; 16(5):821-47. https://doi.org/10.18433/J3VW2F

7. Merlet N, Busseuil D, Rheaume E, Tardif J-C. Cardiac Consequences of Anti-Inflammatory Drugs in Experimental Models. Antiinflamm Antiallergy Agents Med Chem. 2013; 12(1):24-35. https://doi.org/10.2174/1871523011312010005

8. Elfahmi, Woerdenbag HJ, Kayser O. Jamu: Indonesian traditional herbal medicine towards rational phytopharmacological use. J Herb Med [Internet]. 2014; 4(2):51-73. https://doi.org/10.1016/j.hermed.2014.01.002

9. Mollik MAH, Hossan MSH, Paul AK, Taufiq-Ur-Rahman M, Jahan R, Rahmatullah M. A comparative analysis of medicinal plants used by folk medicinal healers in three districts of Bangladesh and inquiry as to mode of selection of medicinal plants. Ethnobot Res Appl. 2010; 8:195-218. https://doi.org/10.17348/era.8.0.195-218

10. Rustam M, Ifora I, Fauziah F. Journal of Drug Delivery and Therapeutics Potential Anti - Inflammatory Effects of Eriocitrin : A Review. 2022; 12(3):187-92. https://doi.org/10.22270/jddt.v12i3.5456

11. Mulia A, Oktavia S, Ifora I. Pharmacological Properties of ∆ ( 9 ) - Tetrahydrocannabinol : A Review. 2021; 0990(1):1-8.

12. Kumar S, Bajwa BS, Kuldeep S, Kalia AN. Jancova P 2010 PHASE II DRUG METABOLIZING ENZYMES.pdf. 2013; 2(2):272-81.

13. Elgorashi EE, McGaw LJ. African plants with in vitro anti-inflammatory activities: A review. South African J Bot. 2019; 126:142-69. https://doi.org/10.1016/j.sajb.2019.06.034

14. Souri MS, Oktavia S, Ifora I. Asian Journal of Pharmaceutical Research and Development. Asian J Pharm Res Dev. 2021; 9(2):47-52. https://doi.org/10.22270/ajprd.v9i2.941

15. Sari DP, Bellatasie R, Ifora I. Anti-Inflammatory Properties of Coriandrum Sativum. 2021; 4(2):34-8.

16. Auliana FR, Ifora I, Fauziah F. Asian Journal of Pharmaceutical Research and Development. Asian J Pharm Res Dev Open. 2022; 10(1):79-83. https://doi.org/10.22270/ajprd.v10i1.1077

17. Azab A, Nassar A, Azab AN. Anti-inflammatory activity of natural products. Molecules. 2016; 21(10):1-19. https://doi.org/10.3390/molecules21101321

18. Ifora I, Fauziah F, Mayora SA. Aktivitas Anti-inflamasi dan Daya Hambat Siklooksigenase-2 Ekstrak Etanol Daun Tembelekan ( Lantana camara L .). J Farm Higea. 2020; 12(1):32-9. https://doi.org/10.36490/journal-jps.com.v3i1.33

19. Ifora, Arifin H, Silvia R. Efek Antiinflamasi Krim Ekstrak Etanol Daun Kirinyuh ( Chromolaena odorata (L) R.M. King & H. Rob ) Secara Topikal dan Penentuan Jumlah Sel Leukosit Pada Mencit Putih Jantan. J Farm Higea. 2017; 9(1):68-76. https://doi.org/10.33086/mhsj.v1i2.602

20. Shi WR, Liu Y, Wang XT, Huang QY, Cai XR, Wu SR. Antitumor efficacy and mechanism in hepatoma H22-bearing mice of brucea javanica oil. Evidence-based Complement Altern Med. 2015; 2015. https://doi.org/10.1155/2015/217494

21. NoorShahida A, Wong TW, Choo CY. Hypoglycemic effect of quassinoids from Brucea javanica (L.) Merr (Simaroubaceae) seeds. J Ethnopharmacol. 2009; 124(3):586-91. https://doi.org/10.1016/j.jep.2009.04.058

22. Ifora I, Kardela W, Yora HYM. Uji Aktivitas Antikolesterol Ekstrak Etanol Buah Malur ( Brucea Javanica ( L .) Merr ) terhadap Mencit Putih Jantan Hiperkolesterolemia. J Farm Higea. 2019; 11(1):2-3. https://doi.org/10.36490/journal-jps.com.v3i1.33

23. Simamora A, Timotius KH, Santoso AW, Simamora A, Timotius KH. Antidiabetic , Antibacterial and Antioxidant Activities of Different Extracts from Brucea javanica ( L .) Merr Seeds. 2019; 11(3):479-85. https://doi.org/10.5530/pj.2019.11.76

24. Abbas M, Shahid M, Rehman HM, Sharif S, Muhammad R, Khan A, et al. Screening of Selected Medicinal Plants for Secondary Metabolites. Abstr Accept poster Present in11 Int 23 Natl Chem Conf held NCEPC, Univ Peshawar (October 15-17, 2012). 2012; 8(3):119.

25. Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the Rat as an Assay for Antiinflammatory. Exp Biol Med. 1962; 3(111):544-7. https://doi.org/10.3181/00379727-111-27849

26. Crunkhorn P, Meacock SCR. Mediators of the inflammation induced in the rat paw by carrageenin. Br J Pharmacol. 1971; 42(3):392-402. https://doi.org/10.1111/j.1476-5381.1971.tb07124.x

27. Vinegar R, Scrheiber W, Hugo R. Biphasic Development of Carragenin Edema in Rats. J Pharmacol Exp Ther. 1969; 166(1).

28. Nathan C. Points of control in inflammation. Nature. 2002; 420(December):846-52. https://doi.org/10.1038/nature01320

29. Muliasari H, Hamdin CD, Aulia N, Hariyati I, Ihsan M. The proposed mechanism of action of Brucea javanica (L) Merr seed in experimentally diabetic rats. AIP Conf Proc. 2019; 2199(December). https://doi.org/10.1063/1.5141314

30. Ablat A, Mohamad J, Awang K, Shilpi JA, Arya A. Evaluation of antidiabetic and antioxidant properties of Brucea javanica seed. Sci World J. 2014; 2014. https://doi.org/10.1155/2014/786130

31. Almira D, Subaidah WA, Ananto AD, Deccati RF, Muliasari H. In vitro concentration optimization of ethanol extract from Makasar fruit seeds (Brucea javanica L. Merr) as an anti-inflammatory agent. J Pijar Mipa. 2021; 16(5):595-9. https://doi.org/10.29303/jpm.v16i5.2655

32. Ifora DH, Abdillah R. Anti-Inflammatory Activity And Cyclooxygenase-2 Inhibition Of Ethanol Extract From Malur Leaves (Brucea javanica (L.) Merr). J Pharm Sci. 2020; 3(1):7-13. https://doi.org/10.36490/journal-jps.com.v3i1.33

33. Ricciotti E, Fitzgerald GA, Ricciotti E, Fitzgerald GA. Prostaglandins and Inflammation. Arter Thromb Vasc Biol. 2011; 31:986-1000. https://doi.org/10.1161/ATVBAHA.110.207449

34. Fitzpatrick F. Cyclooxygenase Enzymes: Regulation and Function. Curr Pharm Des. 2005; 10(6):577-88. https://doi.org/10.2174/1381612043453144

35. Alessandri AL, Sousa LP, Lucas CD, Rossi AG, Pinho V, Teixeira MM. Resolution of inflammation: Mechanisms and opportunity for drug development. Pharmacol Ther [Internet]. 2013; 139(2):189-212. https://doi.org/10.1016/j.pharmthera.2013.04.006

36. Kulwinder Singh, Monika, Neelam Verma. Gastrointestinal and Cardiovascular Risks of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Time to Translate Knowledge into Practice. Res J Pharm Technol. 2014; 7(5):575-80.

37. Dong SH, Liu J, Ge YZ, Dong L, Xu CH, Ding J, et al. Chemical constituents from Brucea javanica. Phytochemistry [Internet]. 2013; 85:175-84. https://doi.org/10.1016/j.phytochem.2012.08.018

38. Weng Z, Zhang B, Asadi S, Sismanopoulos N, Butcher A, Fu X, et al. Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PLoS One. 2012; 7(3):1-10. https://doi.org/10.1371/journal.pone.0033805

39. Ginwala R, Bhavsar R, Chigbu DGI, Jain P, Khan ZK. Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti-inflammatory activity of apigenin. Antioxidants. 2019; 8(2):1-30. https://doi.org/10.3390/antiox8020035

40. Vazhappilly CG, Ansari SA, Al-Jaleeli R, Al-Azawi AM, Ramadan WS, Menon V, et al. Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases. Inflammopharmacology [Internet]. 2019; 27(5):863-9. https://doi.org/10.1007/s10787-019-00612-6

41. Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, et al. Quercetin, inflammation and immunity. Nutrients. 2016; 8(3):1-14. https://doi.org/10.3390/nu8030167

42. Messina S, Bitto A, Aguennouz M, Mazzeo A, Migliorato A, Polito F, et al. Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice : A comparison study with methylprednisolone. Exp Neurol [Internet]. 2009; 220(2):349-58. https://doi.org/10.1016/j.expneurol.2009.09.015

43. Nicole Cotelle BSP. Role of Flavonoids in Oxidative Stress. Curr Top Med Chem. 2005; 1(6):569-90. https://doi.org/10.2174/1568026013394750

44. Jeremić SR, Šehović SF, Manojlović NT, Marković ZS. Antioxidant and free radical scavenging activity of purpurin. Monatshefte fur Chemie. 2012; 143(3):427-35. https://doi.org/10.1007/s00706-011-0695-z

45. Stanikunaite R, Khan SI, Trappe JM, Ross SA. Cyclooxygenase-2 Inhibitory and Antioxidant Compounds from the Truffle Elaphomyces granulatus. 2009; 578(December 2008):575-8. https://doi.org/10.1002/ptr.2698

46. Ravipati AS, Zhang L, Koyyalamudi SR, Jeong SC, Reddy N, Bartlett J, et al. Antioxidant and anti-inflammatory activities of selected Chinese medicinal plants and their relation with antioxidant content. BMC Complement Altern Med. 2012; 12:5-10. https://doi.org/10.1186/1472-6882-12-173

47. Jabeur I, Martins N, Barros L, Calhelha RC, Vaz J, Achour L, et al. Contribution of the phenolic composition to the antioxidant, anti-inflammatory and antitumor potential of Equisetum giganteum L. and Tilia platyphyllos Scop. Food Funct. 2017; 8(3):975-84. https://doi.org/10.1039/C6FO01778A

48. Jastrząb A, Jarocka-Karpowicz I, Markowska A, Wroński A, Gȩgotek A, Skrzydlewska E. Antioxidant and Anti-inflammatory Effect of Cannabidiol Contributes to the Decreased Lipid Peroxidation of Keratinocytes of Rat Skin Exposed to UV Radiation. Oxid Med Cell Longev. 2021; 2021. https://doi.org/10.1155/2021/6647222